In breast cancer patients, high tissue levels of uPA and PAI-1 are associated with a poor prognosis, early disease relapse and predict treatment response and resistance (Foekens et al. 2000; Borstnar et al. 2002; Witte et al. 1999b; Gouri et al. 2016). The gene discussed is PLAU; the disease is breast carcinoma.